Evidence map›Paper›PMID 32297857›Full record

ArticleeLife2020

Enhancer architecture sensitizes cell specific responses to

Yi Kuang, Ohad Golan, Kristina Preusse, Brittany Cain, Collin J Christensen, Joseph Salomone, Ian Campbell, FearGod V Okwubido-Williams, Matthew R Hass, Zhenyu Yuan and 6 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Biophysics of Notch Signaling.Annual review of biophysics · 2021
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Yi Kuang *Graduate Program in Molecular and Developmental Biology, Cincinnati Children's Hospital Research Foundation, Cincinnati, United States.ORCID 0000-0002-1509-3620
Ohad Golan *School of Neurobiology, Biochemistry and Biophysics, George S. Wise Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel.
Kristina PreusseDivision of Developmental Biology, Cincinnati Children's Hospital, Cincinnati, United States.
Brittany CainDepartment of Biomedical Engineering, University of Cincinnati, Cincinnati, United States.
Collin J ChristensenDepartment of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, United States.ORCID 0000-0002-6932-5554
Joseph SalomoneGraduate Program in Molecular and Developmental Biology, Cincinnati Children's Hospital Research Foundation, Cincinnati, United States.
Ian CampbellDepartment of Biomedical Engineering, University of Cincinnati, Cincinnati, United States.
FearGod V Okwubido-WilliamsDepartment of Biomedical Engineering, University of Cincinnati, Cincinnati, United States.
Matthew R HassDivision of Developmental Biology, Cincinnati Children's Hospital, Cincinnati, United States.
Zhenyu YuanDepartment of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, United States.
Nathanel EaferganSchool of Neurobiology, Biochemistry and Biophysics, George S. Wise Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel.
Kenneth H MobergDepartment of Cell Biology, Emory University and Emory University School of Medicine, Atlanta, United States.
Rhett A KovallDepartment of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, United States.ORCID 0000-0003-0520-1613
Raphael KopanDivision of Developmental Biology, Cincinnati Children's Hospital, Cincinnati, United States.
David SprinzakSchool of Neurobiology, Biochemistry and Biophysics, George S. Wise Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0001-6776-6957
Brian GebeleinDivision of Developmental Biology, Cincinnati Children's Hospital, Cincinnati, United States.ORCID 0000-0001-9791-9061
Cincinnati Children's Hospital Medical Center · USTel Aviv University · ILUniversity of Cincinnati · USUniversity of Cincinnati Medical Center · USEmory University · US

Funding

Medical Scientist Training ProgramT32GM063483 · NIGMS · UNIVERSITY OF CINCINNATI · PI KHURANA HERSHEY, GURJIT K. · 2002 to 2022
$6.7M
Molecular mechanisms of transcriptional regulation in the Notch pathwayR01CA178974 · NCI · UNIVERSITY OF CINCINNATI · PI KOVALL, RHETT ALLEN · 2013 to 2017
$1.6M
National Science Foundation 1715822NCI NIH HHS R01 CA178974NIGMS NIH HHS T32 GM063483NIH HHS CA163653
6 · The paper itself

Abstract

Notch pathway haploinsufficiency can cause severe developmental syndromes with highly variable penetrance. Currently, we have a limited mechanistic understanding of phenotype variability due to gene dosage. Here, we unexpectedly found that inserting an enhancer containing pioneer transcription factor sites coupled to Notch dimer sites can induce a subset of

Indexed as

Models, GeneticModels, TheoreticalAnimalsDrosophilaDrosophila ProteinsEnhancer Elements, GeneticHaploinsufficiencyPhenotypeReceptors, NotchDrosophila ProteinsN protein, DrosophilaReceptors, NotchCdk8-Kinase moduledegradationdevelopmental biologyD. melanogasterenhancerhaploinsufficiencyNotch signalingtranscription factor binding sites

Identifiers

PMID32297857
PMCPMC7213981
OpenAlexW3016473370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.